Placing a new product on the market

In the first quarter of 2019, we will introduce gb ONCO products from the BCR-ABL detection line:

gb ONCO BCR-ABL MINOR

gb ONCO BCR-ABL MINOR

gb ONCO BCR-ABL MINOR expands the family of kits intended for a quantitative determination of the BCR-ABL1 fusion gene expression against the background of a reference gene (ABL1, GUSB). Detection method is based on one-step RT-qPCR enabling quick and easy determination.

gb ONCO BCR-ABL MICRO

gb ONCO BCR-ABL MICRO

gb ONCO BCR-ABL MICRO expands the family of kits intended for a quantitative determination of the BCR-ABL1 fusion gene expression against the background of a reference gene (ABL1, GUSB). Detection method is based on one-step RT-qPCR enabling quick and easy determination.

gb ONCO BCR-ABL DETECT

gb ONCO BCR-ABL DETECT

gb ONCO BCR-ABL DETECT is intended for a qualitative determination of a type of the BCR-ABL1 fusion gene alteration.  Apart from commonly occurring fusions the kit detects rare alterations as well. Detection method based on one-step RT-qPCR ensures quick, less laborious and, above all, semiquantitative determination of the fusion type, while sophisticated system of controls ensures validity of the result and its adequate interpretation.

I am interested in more info